To examine the possible involvement of insulin and glucose in regulation of pancreatic islet gene expression, hyperinsulinemic (insulin infusion 4.1 mU/kg per min) clamps were performed for 12 h in rats at two different levels of glycemia (either 3 or 8 mM). A control group received a saline infusion for 12 h. At the end of the 12-h study period, pancreatic RNA was extracted, proinsulin and amylin mRNAs were measured on total RNA, and glucokinase and glucose transporter (GLUT-2) mRNAs were measured on poly(A)+ RNA by dot blot analysis. In insulin-infused hypoglycemic rats, there was a 58% decrement in proinsulin mRNA (P less than 0.01) relative to levels in controls, with no change in amylin, glucokinase, or islet GLUT-2 mRNAs. In insulin-infused hyperglycemic rats, there was a comparable decrement (44%, P less than 0.01) in proinsulin mRNA and a smaller decrement in GLUT-2 mRNA (32%, P less than 0.05), with no change in amylin or glucokinase mRNAs relative to levels in control animals. These studies suggest that insulin has a negative feedback inhibitory effect on its own synthesis. The mechanism of inhibition is unknown. It could be a direct effect of insulin on its own transcription, or alternatively an indirect effect mediated by humoral or neural factors. Sustained hyperinsulinemia may lead to suppression of normal islet beta cells and may […] 
Introduction
Feedback inhibition ofinsulin secretion by insulin was initially observed in 1941 by Best and Haist (1) . These results were verified by isolated islet and pancreas perfusion studies in vitro (2, 3) and later confirmed in man. The in vivo experiments in man utilized insulin plus glucose infusions to maintain euglycemia and measured inhibition of C-peptide secretion (4) (5) (6) (7) . The studies documented that in normal man (4, 5, 7) , in obese subjects (4) , and in noninsulin-dependent diabetes mellitus subjects (6) , both basal and stimulated insulin secretion is inhibited by insulin itself.
The effects of insulin on insulin production by pancreatic islet beta cells have been assessed in rats after chronic administration of insulin and in rats bearing insulinomas (8) (9) (10) . Both conditions result in marked islet atrophy and suppression of insulin gene expression. The effects of insulin are difficult to interpret in these studies, since the animals were both hyperinsulinemic and hypoglycemic. Because fasted rats are also hypoglycemic but hypoinsulinemic, another condition associated with reduced insulin gene expression, this finding suggested that the major determinant of insulin gene expression is ambient plasma glucose concentrations (11) . The question of whether insulin per se regulates its own synthesis has not been rigorously addressed because in none of these studies were plasma insulin levels fixed, and plasma glucose varied.
In the present studies this question was examined by prolonged infusions of insulin while maintaining blood glucose constant at either low or high levels. The results demonstrated that elevated plasma insulin, independent of the ambient glucose concentration, caused a marked reduction in proinsulin mRNA. Other islet beta cell-specific mRNAs, such as the islet glucose transporter (GLUT-2),' glucokinase, and amylin, did not follow this pattern.
Methods
Experimental animals. Adult male Wistar rats (300-380 g) with free access to water and, when not fasting, to rat chow (65% energy intake as carbohydrate) were used in these studies. The same rats were also used in a study of GLUT-2 mRNA levels in cardiac and skeletal muscle (Kraegen, E. W., J. A. Sowden, M. B. Halstead, P. W. Clark, C. Campbell, K. J. Rodnick, D. J. Chisholm, and D. E. James, manuscript submitted for publication). Rats were housed in a temperature-controlled room (22±1°C) with a 12:12-h light/dark cycle (lights on 0600). Rats for metabolic studies were housed in individual cages after cannula implantation.
Influence ofhyperinsulinemia on islet gene expression. Rats for hyperinsulinemic clamp studies were fitted with cannulas introduced into the carotid artery and jugular vein as previously described ( 12) . Studies were conducted 3-5 d after catheter implantation, on animals in the unrestrained, sedentary, conscious state after food withdrawal.
To examine the possible involvement ofinsulin and glucose in regulating islet gene expression, hyperinsulinemic (insulin infusion 4.1 mU/kg per min) clamps were performed for 12 h. Food was removed from animals at the start ofthe 12-h study period (0700). Two insulininfused groups were studied, clamped at either a low (3 mM) or high (8 mM) plasma glucose level by an appropriate variable rate glucose infusion. In addition, a control group (saline infusion only) was studied.
Blood samples (50 Ml) for measuring glucose and adjusting the glucose infusion rate were taken at 20-30-min intervals for 2 h. As glucose requirement varied only slightly after this time, subsequent samples at 60-min intervals until completion were found to be adequate. Larger samples (400 Mi) were taken at 0, 6, and 12 h for insulin and nonesterified fatty acids (NEFA) assays. Cells were resuspended and returned after the 0-and 6-h samples. After 12 h, tissues were removed and rapidly frozen for determination of islet mRNA levels. Hybridization probes. The probes used for mRNA analysis were (a) rat proinsulin I cDNA fragment, 304 bp ofcoding information (14) ; (b) a 2.2-kb rat GLUT-2 cDNA isolated from a rat liver cDNA library with a human GLUT-2 clone (15), shown by sequence analysis to be identical to that ofthe published rat GLUT-2 clone (16); (c) a 441-bp rat islet amylin cDNA fragment (kindly provided by Donald F. Steiner, University of Chicago, Chicago, IL) in PGEM-4Z vector (Promega Corp., Madison, WI); and (d) rat islet glucokinase cDNA (17) , kindly provided by Mark Magnuson (Vanderbilt University, Nashville, TN). The cDNA fragments were subcloned in pGEM (Promega Corp.) or Bluescript SK+ (Stratagene Inc., La Jolla, CA) plasmids. Uniformly labeled [32P]cRNA probes were transcribed according to a protocol provided by the suppliers and as previously described (18) .
Quantitation ofislet mRNA. Poly(A)+ RNA was isolated from total pancreatic RNA and Northern blot analysis performed according to standard methods (19) . Quantitation of all mRNAs concentrations, including proinsulin, GLUT-2, amylin, and glucokinase, was by dot blot hybridization, essentially as described (20) . 10-, 5-, and 2.5-Mg aliquots of total pancreatic RNA for determination of proinsulin or amylin mRNA, or poly(A)+ RNA for determination of GLUT-2 and glucokinase mRNA, were dissolved in 15% formaldehyde in lOX standard saline citrate (SSC), and blotted onto Nytran membranes (Schleicher & Schuell, Inc., Keene, NH). Membranes were incubated with appropriate probes (5 X 106 cpm/ml) for 18 h at 60°C in 50% formamide, 5X SSPE, and then washed at 60°C in 0.1% SDS. Blots were exposed to Kodak XAR5 film at -70°C using intensifying screens (Cronex Lightning Plus; E. I. Dupont de Nemours Co., Wilmington, DE). The amount of mRNA in each sample, determined in duplicate, was measured by densitometric analysis comparing the intensity ofthe dots. The coefficients of variation for quantitative dot blot analysis of proinsulin mRNA (see Table I ) were such that differences > 35%
would be detected at the p = 0.05 level.
Membranes were stripped after hybridization and rehybridized with uniformly labeled [32P]actin cRNA (1 ,200-bp chicken beta-actin cDNA subcloned in pGEM-l) as an mRNA control. It was determined, however, that actin mRNA under the conditions studied was not a stable mRNA, but declined with insulin infusions (see Table I ). Islet mRNA was, therefore, normalized to DNA concentration of each sample.
Statistical analysis. All experimental data are expressed as mean±SEM. Statistical analyses were performed using paired or unpaired two-tailed Student's t tests or a two-way ANOVA as appropriate. 
Results
Effects ofinsulin infusions on islet gene expression. The effects of 12-h hyperinsulinemic clamps at two different glucose levels on circulating plasma glucose, serum insulin, and NEFA levels are shown in Table I . Plasma glucose was maintained at 3 mM in the low glucose-infused animals and 8 mM in the high glucose-infused animals, compared with 6 mM in control ani- Fig. 1 . Proinsulin mRNA concentrations appeared reduced in both groups of hyperinsulinemic animals (lanes I and 2) relative to that in saline-infused control animals (lane 3). This was further quantitated by dot blot analysis.
The results of 12-h hyperinsulinemic clamps at two plasma glucose levels on pancreatic RNA yields and islet mRNA levels quantitated by dot blot analysis are shown in Table I . Although RNA yields were not significantly altered by insulin infusions, there was a trend toward a decrease. Pancreatic actin mRNA was significantly reduced in both experimental conditions, so islet mRNA concentrations were expressed per microgram pancreatic DNA. Insulin infusions with hypoglycemia (n = 5) resulted in a 58% decline in proinsulin mRNA (P < 0.01) compared with levels in saline-infused controls (n = 5), similar to results previously described (9) . In contrast, there were no significant changes noted in amylin, glucokinase, or GLUT-2 mRNAs in insulin-infused hypoglycemic rats.
When animals were made hyperinsulinemic and clamped at high glucose levels, a surprising 44% reduction in proinsulin mRNA (P < 0.01) was observed as well. This condition also resulted in a smaller decline in GLUT-2 mRNA (32%, P < 0.05), with no change in amylin mRNA or glucokinase mRNA versus levels in saline-infused control animals. glucose as the major regulatory component (8) (9) (10) (11) (21) (22) (23) (24) (25) (26) . The results of the current study tend to undermine this, since suppression at either low or high glucose levels was observed, whereas the serum insulin was held constant at a level - [20] [21] [22] [23] [24] [25] times the basal concentration. In previous studies in animals bearing insulinomas and in chronic insulin-infused animals, marked suppression ofproinsulin mRNA was noted in pancreatic islet beta cells by in situ quantitative hybridization analysis (9) . In those studies, the animals were both hyperinsulinemic and hypoglycemic. Only in the current study were animals subjected to a sustained period of hyperinsulinemia while plasma glucose levels were clamped at low or high levels. Under these conditions it appears that insulin itself is responsible for the suppression.
Discussion
That glucose per se can regulate insulin gene expression appears to have been well established by experiments conducted both in vivo and in vitro. Fasting is associated with low glucose levels and low proinsulin mRNA levels (1 1). Glucose infusion into rats resulted in hyperglycemia and increased proinsulin mRNA (25) . Isolated islets and islet beta cells in culture respond to changes in glucose concentrations with alterations ofinsulin gene expression (22) (23) (24) 26) . The results ofthe current studies, however, now suggest that the insulin gene is subject to dual control by both plasma glucose and serum insulin levels. In the presence ofhyperinsulinemia and high glucose levels, insulin appeared to have a dominant negative effect on insulin gene expression.
The effects ofinsulin on insulin gene expression were somewhat specific in that glucokinase and amylin, two other beta cell-specific gene products (27) (28) (29) , were not changed under these conditions. The GLUT-2 gene was suppressed only at high glucose levels. Thus, the effects of insulin on insulin gene expression were larger and more consistent than these changes in expression of the other islet genes. The effects of insulin infusions in vivo on pancreatic actin mRNA have not been previously reported, but we have noted that actin mRNA is not a stable pancreatic or islet mRNA under several experimental conditions (Koranyi, L., and M. A. Permutt, unpublished observations).
The rather large (> 50%) reduction in proinsulin mRNA after only 12 h of insulin infusion was surprising in light ofthe previously estimated half-life of > 24 h in rat islets and in cultured insulinoma cells (23, 24 (Fig. 2) . Extending the search to sequences immediately adjacent to the PEPCK insulin response sequence, a region of 12 bp identity is seen in the rat insulin I promoter.
The core sequence TTTTA is also observed in the promoter region of the rat insulin II gene. This represents the first study ofthe effects of hyperinsulinemia at both low and high plasma glucose levels on expression of islet amylin, glucokinase, and GLUT-2 genes. The effects of insulin injection and chronic insulin infusions in rats on islet GLUT-2 expression have been reported (10) . 3 h after an insulin injection, islet GLUT-2 mRNA concentration was not changed; but insulin infusion for 4 d resulted in an 85% decrease. In the current experiments, after 12 h of insulin infusion, there was no reduction in GLUT-2 mRNA in hypoglycemic rats relative to controls, but there was a reduction in hyperglycemic animals (Table I ). In chronic exercised rats, GLUT-2 mRNA levels were also unchanged (20) . For all ofthe above conditions, as in the current experiments, there was no correlation between proinsulin mRNA and GLUT-2 mRNA (r = 0.43, P = 0. 13). Thus, although the islet GLUT-2 gene may be regulated under some conditions, these data together indicate that it is not coordinately regulated with the insulin gene.
The activity of pancreatic islet glucokinase may be ratelimiting for beta-cell glucose metabolism (27) . Few studies have been reported ofglucokinase gene expression after in vivo manipulations. No change in islet glucokinase mRNA concentration was observed in fasted rats (28) . Chronic training ofrats resulted in suppression ofboth basal and glucose-induced insulin secretion, associated with coordinate reduction of proinsulin and glucokinase mRNAs (20) . In the current study, although there was no change in glucokinase mRNA levels, there was a significant correlation between glucokinase mRNA and proinsulin mRNA concentrations (r = 0.79, P = 0.0004), suggesting perhaps that expression of these genes is coordinately regulated, as was noted in chronically trained rats (20) .
Very little is known about regulation ofamylin biosynthesis in man or experimental animals (29) . Amylin gene expression in islets is relatively high, being on the order of 10% that of insulin in the rat (36) . Fasting and streptozotocin diabetes were associated with decreased amylin mRNA concentrations (37) , whereas administration of pharmacologic glucocorticoids resulted in enhanced insulin and amylin mRNA levels (38). In neonatal rats, both obesity and high carbohydrate feeding were found to have marked stimulatory effects on amylin gene expression (39) . In those experiments there was a significant correlation between amylin and insulin gene expression for all animals during development, regardless of diet. In the current studies, although there was a trend toward suppression ofamylin gene expression with hyperinsulinemia and hypoglycemia, these changes were not significant. However, the coefficient of variation for amylin mRNA (see Table I ) was too large to detect differences this small at the P = 0.05 level.
The feedback inhibitory effect of insulin on its own expression may be an important physiological control mechanism. In the immediate postprandial period, hyperglycemia stimulates acute insulin release to restore euglycemia. The high concentrations of insulin to which islet beta cells are subjected may have little effect on insulin gene expression, as the insulin levels rapidly fall (minutes to hours) with restoration of plasma glucose concentration. Sustained hyperinsulinemia, however (hours to days), such as occurs during prolonged insulin infusion or in patients with insulin resistance and hyperinsulinemia, may result in suppression of normal islets. This observation raises the intriguing possibility that the hyperinsulinemia that accompanies obesity and the early phases of noninsulindependent diabetes mellitus may contribute to the ultimate development of insulin lack that is characteristic of this disorder.
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